CELSUS THERAPEUTICS PLC's ticker is CLTX and the CUSIP is 15119A202. A total of 14 filers reported holding CELSUS THERAPEUTICS PLC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 941,754 | $5,838,000 | 0.29% |
| DAFNA Capital Management LLC | 43,900 | $272,000 | 0.26% |
| SABBY MANAGEMENT, LLC | 819,911 | $4,510,000 | 0.19% |
| Cormorant Asset Management, LP | 103,000 | $639,000 | 0.17% |
| Baker Brothers Advisors | 673,887 | $3,706,000 | 0.04% |
| Knoll Capital Management, LLC | 14,155 | $78,000 | 0.04% |
| Ground Swell Capital, LLC | 600 | $3,000 | 0.01% |
| HighTower Advisors, LLC | 30,000 | $186,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 2,000 | $12,000 | 0.00% |
| FRANKLIN RESOURCES INC | 701,754 | $3,860,000 | 0.00% |